NewLink Genetics (NLNK) Tops Q4 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NLNK Hot Sheet
Join SI Premium – FREE
NewLink Genetics (NASDAQ: NLNK) reported Q4 EPS of ($0.75), $0.17 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $6.06 million versus the consensus estimate of $4.89 million.
For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Twilio (TWLO) PT Raised to $320 at Tigress Financial Partners
- McDonald's posts better-than-expected third-quarter comparable sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
